Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics
UNCY Price/Volume Stats
| Current price | $0.62 | 52-week high | $1.82 |
| Prev. close | $0.61 | 52-week low | $0.20 |
| Day low | $0.61 | Volume | 586,300 |
| Day high | $0.65 | Avg. volume | 1,368,418 |
| 50-day MA | $0.65 | Dividend yield | N/A |
| 200-day MA | $0.64 | Market Cap | 64.35M |
UNCY Stock Price Chart Interactive Chart >
Unicycive Therapeutics, Inc., (UNCY) Company Bio
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
UNCY Price Returns
| 1-mo | -9.36% |
| 3-mo | 52.63% |
| 6-mo | 40.91% |
| 1-year | -25.39% |
| 3-year | -63.31% |
| 5-year | N/A |
| YTD | -21.93% |
| 2024 | -8.47% |
| 2023 | 60.69% |
| 2022 | -73.79% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...